ISC · Japan
Bone marrow stem cell therapy
A treatment in which donor-derived (allogeneic) bone marrow stem cells are administered by intravenous infusion.
Organised by the International Stem Cell Association (ISC), Japan. Treatment venue: BRM Clinic, Bangkok.
This is private-pay treatment and is not covered by public health insurance in Japan or Thailand. For the cost of treatment, please contact us.
Alchemist Medical International presents this treatment in partnership with the International Stem Cell Association (ISC), Japan. The procedure itself is performed at BRM Clinic in Bangkok, under the responsibility of the clinic and its physicians. Alchemist Medical International does not provide the medical treatment.
Why bone marrow
Bone marrow is one of the richest sources of adult stem cells in the body, containing both mesenchymal stem cells and haematopoietic stem cells. The cells used in this treatment are donor-derived. The procedure is carried out by specialist physicians under the clinic's medical protocols, and suitability is assessed for each patient beforehand.
How the treatment works
The treatment is completed in a single visit and takes about one hour, including consultation and infusion.
- 01
Donor cells
Bone marrow stem cells from a screened donor are used.
- 02
Prepare
The cells are concentrated and purified in a sterile laboratory.
- 03
Infusion
The prepared cells are administered by intravenous infusion.
How to book
Treatments are held once a month, in the morning, at BRM Clinic in Bangkok.
- 01
Reserve
Book at least one month before the treatment date.
- 02
Payment
Complete payment to secure the reservation.
- 03
Consent
Sign the consent agreement and complete a private interview with ISC by video call.
- 04
Treatment
Held in the morning. About one hour, including consultation and infusion.
Exosomes
Exosomes are nanoscale vesicles that carry microRNA, proteins and growth factors between cells. The figures below are measured values for the bone marrow-derived preparation, analysed by Theoria Science.
- 2.62 trillion
- exosomes per 2 cc vial
- 1.31 trillion
- particles per ml
- 1,056
- types of microRNA analysed
- 80
- growth factors analysed
These are measurements of composition. They do not indicate that a therapeutic effect has been demonstrated.
Important information
- This treatment uses cells that have not been approved as a pharmaceutical product by the regulatory authorities of Japan, Thailand, the United States or the European Union. It is provided as private medical practice under the responsibility of the treating physician.
- The cells are donor-derived (allogeneic) and are not collected from the patient. They are sourced from donors in Eastern Europe and Russia. Please confirm with the treating physician how donors are screened and which facility prepares the cells.
- No equivalent therapy has received marketing approval in Japan, Thailand, the United States or the European Union. Approval status should be confirmed with the treating physician before deciding.
- Because the cells are donor-derived, immune or rejection reactions and the transmission of infection cannot be ruled out. Other possible effects include fever, rash, headache and, rarely, allergic reaction after infusion. Suitability is assessed individually and treatment may be declined.
- Results vary between individuals. No specific outcome is promised.
- This page is provided for information. It is not medical advice, and it does not recommend the use of any particular product or treatment.
Enquiries and consultation
For reservations or to arrange a consultation, please contact the International Stem Cell Association (ISC).
Contact usInformation on this site is provided for general reference. It is not medical advice and does not promote the use of any product.